Why the study?
Does the Medicare Transitional Care Management (TCM) bundle reduce hospital 30-day readmission rates in adults in the US health care system?
Does the Medicare Transitional Care Management (TCM) bundle reduce hospital 30-day readmission rates in adults in the US health care system?
Evidence for the effectiveness of Medicare's Transitional Care Management (TCM) bundle in reducing 30-day readmissions is currently limited to a few non-randomized studies, highlighting the need for further rigorous research.
TCM should not yet alter practice; leaves open readmission benefit pending RCTs.
To reduce readmission rates and prevent adverse outcomes after discharge, hospitals have begun implementing "transitional care" initiatives. This systematic review identifies research on the particular set of services now reimbursable by Medicare (transitional care management [TCM]) and evaluates the studies for program effectiveness. Results of 3 databases were screened for peer-reviewed journal articles published between January 2004 and 2015 that report on readmissions of adults in the US health care system under the Medicare TCM bundle. ClinicalTrials.gov was queried for funded studies. Of 969 identified studies, 77 met inclusion criteria for relevance to transitional care and appropriateness of population and setting. Of these, only 3 articles incorporated all required elements for TCM service. Although 2 were program improvement designs and none were randomized controlled studies, each report reduced readmission rates. Evidence for TCM effectiveness is limited. Additional study of TCM implementation and programmatic support for TCM is warranted.
No takes yet. Share an insight, caveat, or question.
Roper et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: